197 related articles for article (PubMed ID: 16277870)
21. [Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):77-9. PubMed ID: 16468648
[TBL] [Abstract][Full Text] [Related]
22. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
23. The folate receptor as a molecular target for tumor-selective radionuclide delivery.
Ke CY; Mathias CJ; Green MA
Nucl Med Biol; 2003 Nov; 30(8):811-7. PubMed ID: 14698784
[TBL] [Abstract][Full Text] [Related]
24. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
Ke CY; Mathias CJ; Green MA
J Am Chem Soc; 2005 May; 127(20):7421-6. PubMed ID: 15898791
[TBL] [Abstract][Full Text] [Related]
25. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
26. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans.
Lee D; Lockey R; Mohapatra S
J Nanosci Nanotechnol; 2006; 6(9-10):2860-6. PubMed ID: 17048492
[TBL] [Abstract][Full Text] [Related]
27. [Study on the tumor cell targetability of folate-conjugated albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR; Qiao XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):165-8. PubMed ID: 15071905
[TBL] [Abstract][Full Text] [Related]
28. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells.
Pinhassi RI; Assaraf YG; Farber S; Stark M; Ickowicz D; Drori S; Domb AJ; Livney YD
Biomacromolecules; 2010 Jan; 11(1):294-303. PubMed ID: 20014825
[TBL] [Abstract][Full Text] [Related]
29. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
[TBL] [Abstract][Full Text] [Related]
30. Folate-receptor-targeted radionuclide imaging agents.
Ke CY; Mathias CJ; Green MA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1143-60. PubMed ID: 15094212
[TBL] [Abstract][Full Text] [Related]
31. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
32. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy.
Tekade RK; Dutta T; Tyagi A; Bharti AC; Das BC; Jain NK
J Drug Target; 2008 Dec; 16(10):758-72. PubMed ID: 18985508
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.
Guo W; Hinkle GH; Lee RJ
J Nucl Med; 1999 Sep; 40(9):1563-9. PubMed ID: 10492380
[TBL] [Abstract][Full Text] [Related]
34. Targeted gene delivery to cancer cells with nanometric DNA particles enveloped with folic acid using a polymerisable anchor.
Zuber G; Muller CD; Behr JP
Technol Cancer Res Treat; 2005 Dec; 4(6):637-43. PubMed ID: 16292883
[TBL] [Abstract][Full Text] [Related]
35. Targeting therapeutic and imaging agents to folate receptor positive tumors.
Reddy JA; Allagadda VM; Leamon CP
Curr Pharm Biotechnol; 2005 Apr; 6(2):131-50. PubMed ID: 15853692
[TBL] [Abstract][Full Text] [Related]
36. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
37. Kinetic limitations of cooperativity-based drug delivery systems.
Licata NA; Tkachenko AV
Phys Rev Lett; 2008 Apr; 100(15):158102. PubMed ID: 18518156
[TBL] [Abstract][Full Text] [Related]
38. Folate-mediated targeting of T cells to tumors.
Roy EJ; Gawlick U; Orr BA; Kranz DM
Adv Drug Deliv Rev; 2004 Apr; 56(8):1219-31. PubMed ID: 15094217
[TBL] [Abstract][Full Text] [Related]
39. Folate receptor-targeted drugs for cancer and inflammatory diseases.
Low PS; Antony AC
Adv Drug Deliv Rev; 2004 Apr; 56(8):1055-8. PubMed ID: 15094205
[No Abstract] [Full Text] [Related]
40. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
